Clinical trial
Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
NCT00062270
Study timeline
Study start (unknown)2003-05-01Date precision: month
Registry last updated2015-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
cisplatinDRUG · verified · RxNorm: cisplatin
docetaxelDRUG · verified · RxNorm: docetaxel
gefitinibDRUG · verified · RxNorm: gefitinib
gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride
conventional surgeryPROCEDURE
neoadjuvant therapyPROCEDURE
radiation therapyRADIATION
Sponsors & collaborators
University of Alabama at Birminghamlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00062270 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.